cabergoline has been researched along with HIV Coinfection in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Autmizguine, J; Boucher, M; Boucoiran, I; Elwood, C; Ferreira, E; Kakkar, F; Money, D; Poliquin, V; Roy, M; Sheehan, NL; Thibaudeau, R; Tulloch, K | 1 |
| Boucoiran, I; Dodin, P; Elwood, C; Money, D; Tremblay-Racine, F; Tulloch, KJ | 1 |
| Buhendwa, L; Firmenich, P; Harries, AD; Kazima, J; Massaquoi, M; Teck, R; Zachariah, R | 1 |
1 review(s) available for cabergoline and HIV Coinfection
| Article | Year |
|---|---|
Cabergoline: a review of its use in the inhibition of lactation for women living with HIV.
Topics: Breast Feeding; Cabergoline; Dopamine Agonists; Female; HIV Infections; Humans; Lactation; Postpartum Period | 2019 |
1 trial(s) available for cabergoline and HIV Coinfection
| Article | Year |
|---|---|
Cabergoline for suppression of puerperal lactation in a prevention of mother-to-child HIV-transmission programme in rural Malawi.
Topics: Adult; Cabergoline; Dopamine Agonists; Ergolines; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lactation; Malawi; Postpartum Period; Prolactin; Rural Population | 2008 |
1 other study(ies) available for cabergoline and HIV Coinfection
| Article | Year |
|---|---|
Evaluation of cabergoline for lactation inhibition in women living with HIV.
Topics: Cabergoline; Ergolines; Female; HIV Infections; Humans; Lactation; Prolactin | 2021 |